VALNEVA and Adimmune partner to commercialize Japanese Encephalitis vaccine in Taiwan

April 10, 2014 European biotechnology company Valneva SE (Valneva) announced today that it has granted vaccine manufacturer Adimmune Corporation certain exclusive rights to its Japanese encephalitis (JE) vaccine in Taiwan. Adimmune will be entitled to register and commercialize Valneva┬┤s JE vaccine under a local trade name and to develop, manufacture and commercialize such a vaccine from bulk product delivered by …